The follow-up on our cohort of women showed that the majority of uncertain ASC-H diagnoses (82.6%) had abnormal colposcopic results and that during the follow-up using ASC-H smears, two out of every three women developed high-grade lesions.
INTRODUCTION
The concept that the presence of atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H) was introduced by the 2001 Bethesda System of cervical cytology classification. This system addresses the need to define a cytological category between atypical squamous cells of undetermined significance (ASCUS) and high-grade squamous intraepithelial lesion (HSIL). 1 The definition of this nomenclature resulted from the ASCUS/LSIL Triage Study (ALTS) carried out between 1996 and 2000, in which interpretations of ASCUS were subcategorized as "equivocal LSIL" (ASCUS-L) and "equivocal HSIL"
(ASCUS-H). Through a consensus among expert pathologists, it was concluded that ASCUS-H represented a cytological category that differed from ASCUS-L and HSIL. 2 ASCUS-H has been seen to present a risk association of 27.2% with cervical cancer precursor lesions, which is higher than the risk association for the ASCUS-L category of 11.4%, but lower than the risk association for HSIL of 44.8%. 2, 3 Subsequent studies, such as a study by Sherman et al.,
detected high-grade lesions (HSIL) in 41% of the women with initial ASC-H smears. 4 Supporting previous findings, Patton obtained a high positive predictive value for lesions of cervical intraepithelial neoplasia (CIN II/III), derived from the ASC-H diagnosis category in a general population of women. 5 Bonvicino et al. used computed data from two medical centers in San Antonio, Texas, United States, in which 260 women diagnosed with ASC-H underwent cytological-histological follow-up, and found that 25.4% had a high-grade lesion at the end of the follow-up period. 6 Using the same methodology in Brazil, Cytryn et al. found high prevalence of high-grade lesions among a total of 57 ASC-H cases. 7 Thus, the abovementioned follow-up studies demonstrated that there are connections between ASC-H smears and high-grade lesions. 4, 6, 7 In Chile, the 2001 Bethesda System was adopted in 2005 via Ordinance Number B232 1771 issued by the Department of Non-Communicable Diseases, within the Division of Disease Prevention and Control. This ordinance standardized the use of the nomenclature that had started to be used in previous years. Although other studies such as Gaete et al. 10 and Yazigi et al. 11 were conducted in Chile, they were limited because they did not discriminate the type of atypia given that they were conducted using cytological reports that were produced before the 2001
Bethesda System was incorporated in Chile. The scarce scientific evidence regarding the ASC-H category among the female population of Chile motivated the present study. 
OBJECTIVE

METHODS
The present research comprises a prospective cohort study on women who were followed up over a three-year period. During 2005-2006, 88,438 cervical cytological smears were collected by midwives using Ayre spatulas and cytobrushes in primary healthcare clinics, in the southern area of Santiago, Chile.
These smear screenings were fixed and sent to Barros Luco Hospital Laboratory (central hospital). In this laboratory, the cytological smears were stained by means of the conventional Pap smear technique and were classified using the national nomenclature system, which is equivalent to the 2001 Bethesda system.
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These tests were processed by a team of cytotechnologists with an average of 20 years of experience. Subsequently, these records were registered in the "Cytological Expert Diagnosis Archive System" at the Chilean Ministry of Health. This provided the cytological-histological database that we searched to obtain data for the present research study.
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The ASC-H cases were selected (n = 106) and the following selection criteria were applied: the women needed to be with- Table 1) .
After applying the selection criteria to the group of women with ASC-H Pap smears, the cohort consisted of 92 women, with a mean age of 38.2 years and an age range from 19 to 71 years.
The follow-up results from this cohort were illustrated using the "Conditional Probabilities Tree Diagram" (Figure 1 ), which begins with the ASC-H Pap smear ("phase 0") and illustrates the tests performed on the women and their outcomes over time.
Squares signify a biopsy and circles indicate a Pap smear.
It needs to be borne in mind that the ASC-H cytological finding is defined as a suspected case (positive Pap smear) in the cervical cancer program. These 92 women who were attended at primary healthcare clinics were managed in accordance with the central hospital's "management algorithm for specialist or cervical pathology clinic treatment from the time of the first atypical Pap", in order to make the diagnosis and/or proceed with treatment.
During the first contact with this clinic, the patient's history was taken, a gynecological examination was made and colposcopy was performed. Colposcopy is considered to be the first procedure for diagnostic confirmation in the management algorithm. As shown in "Phase 1", 76 cases (82.6%) showed abnormal colposcopic findings and required biopsy for histological analysis, while in 16 cases (17.4%), the initial colposcopic findings were normal and were followed up by a Pap test.
The average length of time taken for the patients to complete these medical procedures was 3.15 months, with a minimum of two days and a maximum of 19.6 months.
Subsequently, the cytological-histological results collected in the previous stage were known as "Phase 2". For the group that started with a histological study, the results were distributed as follows: 31 biopsies showed CIN I; 35 showed CIN II/III; three showed carcinoma; and seven were negative. For the group that started with a Pap smear, three of these tests indicated HSIL, 11
were negative for neoplastic cells and two indicated ASC-US.
Given these results, and in accordance with the derivation algorithm, a reassessment was performed and the previous procedures were repeated. Pap and colposcopy were obligatory, while the histological examination was made according to the colposcopic findings.
In "Phase 3" and as a result of the repeated examinations, 12
women were found (through biopsy) to have CIN I; 34 women were found to have CIN II/III; three women were found to have carcinoma and four women were negative. In the cases with Pap smears, 38 tests were performed and most of them (33) of cytological-histological examinations that patients required to obtain a definitive diagnosis was as follows:
• 1 biopsy = 27 women (29.3%);
• 2 biopsies = 46 women (50%);
• 3 biopsies = 8 women (8.7%);
• 4 biopsies = 3 women (3.3%); In evaluating this three-year cytological-histological follow-up period, the 92 women were found to have the following lesion distribution:
• 7 women had invasive carcinoma (7.6%);
• 49 women had high-grade lesions (53.3%);
• 26 women had low-grade lesions (28.2%);
• 10 women had normal cytological outcomes (10.9%). Pap smears performed in a screening program in India, up 8.8%
DISCUSSION
ASC-H is
out of a total of 12,188 Pap smears in South Africa. 13, 14 In Latin America, and specifically in Brazil, Yamamoto et al. Bethesda System (Table 2) . and the "algorithm of diagnostic confirmation". In the first algorithm, it is established that women with atypical smears must be managed at a cervical pathology clinic. 26, 27 The follow-up for our population study was started at a cervical pathology clinic.
The population's demographic profile comprised young women (average age: 38.2 years), which was similar to the populations of several other studies, which had averages ranging from 29 to 38.1 years. It is noteworthy that these outcomes corresponded to women in the screened population (Table 3) . The average length of follow-up in the present study was In our study, 60.9% (56 women) had a definitive high-grade diagnosis (CIN II+) that was verified by biopsy. Comparing this ratio with the literature, we found that it was intermediate between the studies by Saad et al. 16 and Barreth et al., 17 which found that 6% and 79.9% of the women had high-grade lesions, respectively. 18 This is consistent with the results obtained from the majority of the studies observed, which demonstrated CIN II+ prevalences of more than 40%, according to the biopsy results. 3, 5, 6, [17] [18] [19] [20] [21] [22] [23] [24] 29 Our results confirmed that at the time of the first ASC-H report, immediate intervention with colposcopy was necessary, followed by a biopsy. This validates the medical management of ASC-H that is required by the "management algorithm from the time of the first atypical Pap, " which is included in the Chilean Ministry of Health's Clinical Guidelines for Cervical Cancer.
CONCLUSIONS
The follow-up of our cohort of women showed the following:
• The majority of the uncertain ASC-H diagnoses (82.6%) also had abnormal colposcopic results.
• During the follow-up on ASC-H smears, two out of every three women developed high-grade lesions (CIN II+), which were detected after an average of 3.15 months.
• Detection of high-grade lesions in a female population through screening reflects the importance of public health programs within the National Cervical Cancer Research and Control Program in Chile.
